This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Beattie, G. M. Articles by Hayek, A. Search for Related Content PubMed PubMed Citation Articles by Beattie, G. M. Articles by Hayek, A.

Ex Vivo Expansion of Human Pancreatic Endocrine Cells¹

Whittier Institute, Department of Pediatrics, University of California-San Diego School of Medicine, La Jolla, California 92037

Address all correspondence and requests for reprints to: A. Hayek, M.D., Whittier Institute, Department of Pediatrics, 9894 Genesee Avenue, La Jolla, California 92037. E-mail ahayek{at}ucsd.edu

Cell transplantation as a therapy for type 1 diabetes is facilitated by ex vivo cell expansion of pancreatic ß-cells without loss of differentiative characteristics. The aim of this study was to determine the optimal conditions for in vitro growth of functional human pancreatic endocrine tissue. We examined the mitogenicity of matrixes from a variety of cell lines; proliferation was greater in cells growing on matrixes from bladder carcinoma cell lines, especially in monolayers grown on matrix from the human cell line HTB-9. After 14-day culture, there was a more than 100-fold proliferative increase, which was augmented to a more than 200-fold when hepatocyte growth factor/scatter factor was added; however, hepatocyte growth factor/scatter factor induced a rapid decrease in insulin content. Without the growth factor, fetal cell monolayers expanded 4-fold with no insulin loss; however, after 12-fold expansion, the insulin levels decreased to 40% of those in unexpanded cells. Adult islet cells expanded 3-fold without insulin loss. After 5-fold expansion, insulin levels decreased by 25% compared to those in free floating islets while retaining a normal response to secretagogues. Together, these results indicate that HTB-9 matrix provides the best stimulatory effect on replication of human endocrine cells, with little loss of in vitro function.

This article has been cited by other articles:

				A. G. Kayali, L. E. Flores, A. D. Lopez, B. Kutlu, E. Baetge, R. Kitamura, E. Hao, G. M. Beattie, and A. Hayek Limited Capacity of Human Adult Islets Expanded In Vitro to Redifferentiate Into Insulin-Producing {beta}-Cells Diabetes, March 1, 2007; 56(3): 703 - 708. [Abstract] [Full Text] [PDF]

				J. J. Meier, R. Kayed, C.-Y. Lin, T. Gurlo, L. Haataja, S. Jayasinghe, R. Langen, C. G. Glabe, and P. C. Butler Inhibition of human IAPP fibril formation does not prevent beta-cell death: evidence for distinct actions of oligomers and fibrils of human IAPP Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): E1317 - E1324. [Abstract] [Full Text] [PDF]

				T. Kaido, M. Yebra, V. Cirulli, C. Rhodes, G. Diaferia, and A. M. Montgomery Impact of Defined Matrix Interactions on Insulin Production by Cultured Human {beta}-Cells: Effect on Insulin Content, Secretion, and Gene Transcription. Diabetes, October 1, 2006; 55(10): 2723 - 2729. [Abstract] [Full Text] [PDF]

				A. S. Narang and R. I. Mahato Biological and biomaterial approaches for improved islet transplantation. Pharmacol. Rev., June 1, 2006; 58(2): 194 - 243. [Abstract] [Full Text] [PDF]

				C.-Y. Lin, T. Gurlo, L. Haataja, W. A. Hsueh, and P. C. Butler Activation of Peroxisome Proliferator-Activated Receptor-{gamma} by Rosiglitazone Protects Human Islet Cells against Human Islet Amyloid Polypeptide Toxicity by a Phosphatidylinositol 3'-Kinase-Dependent Pathway J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6678 - 6686. [Abstract] [Full Text] [PDF]

				T. Kaido, M. Yebra, V. Cirulli, and A. M. Montgomery Regulation of Human {beta}-Cell Adhesion, Motility, and Insulin Secretion by Collagen IV and Its Receptor {alpha}1{beta}1 J. Biol. Chem., December 17, 2004; 279(51): 53762 - 53769. [Abstract] [Full Text] [PDF]

				T. Kaido, B. Perez, M. Yebra, J. Hill, V. Cirulli, A. Hayek, and A. M. Montgomery {alpha}v-Integrin Utilization in Human {beta}-Cell Adhesion, Spreading, and Motility J. Biol. Chem., April 23, 2004; 279(17): 17731 - 17737. [Abstract] [Full Text] [PDF]

				R. A. Ritzel and P. C. Butler Replication Increases {beta}-Cell Vulnerability to Human Islet Amyloid Polypeptide-Induced Apoptosis Diabetes, July 1, 2003; 52(7): 1701 - 1708. [Abstract] [Full Text] [PDF]

				G. M. Beattie, A. M.P. Montgomery, A. D. Lopez, E. Hao, B. Perez, M. L. Just, J. R.T. Lakey, M. E. Hart, and A. Hayek A Novel Approach to Increase Human Islet Cell Mass While Preserving {beta}-Cell Function Diabetes, December 1, 2002; 51(12): 3435 - 3439. [Abstract] [Full Text] [PDF]

				C. Demeterco, P. Itkin-Ansari, B. Tyrberg, L. P. Ford, R. A. Jarvis, and F. Levine c-Myc Controls Proliferation Versus Differentiation in Human Pancreatic Endocrine Cells J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3475 - 3485. [Abstract] [Full Text] [PDF]

				V. Cirulli, G. M. Beattie, G. Klier, M. Ellisman, C. Ricordi, V. Quaranta, F. Frasier, J. K. Ishii, A. Hayek, and D. R. Salomon Expression and Function of {alpha}v{beta}3 and {alpha}v{beta}5 Integrins in the Developing Pancreas: Roles in the Adhesion and Migration of Putative Endocrine Progenitor Cells J. Cell Biol., September 18, 2000; 150(6): 1445 - 1460. [Abstract] [Full Text] [PDF]

				S. Bonner-Weir, M. Taneja, G. C. Weir, K. Tatarkiewicz, K.-H. Song, A. Sharma, and J. J. O'Neil In vitro cultivation of human islets from expanded ductal tissue PNAS, July 5, 2000; 97(14): 7999 - 8004. [Abstract] [Full Text] [PDF]